HUP0303243A3 - Carbamate compounds for use in preventing and treating bipolar disorder - Google Patents
Carbamate compounds for use in preventing and treating bipolar disorderInfo
- Publication number
- HUP0303243A3 HUP0303243A3 HU0303243A HUP0303243A HUP0303243A3 HU P0303243 A3 HUP0303243 A3 HU P0303243A3 HU 0303243 A HU0303243 A HU 0303243A HU P0303243 A HUP0303243 A HU P0303243A HU P0303243 A3 HUP0303243 A3 HU P0303243A3
- Authority
- HU
- Hungary
- Prior art keywords
- preventing
- bipolar disorder
- carbamate compounds
- treating bipolar
- treating
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 title 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27168101P | 2001-02-27 | 2001-02-27 | |
| US10/081,766 US6562867B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating bipolar disorder |
| PCT/US2002/005297 WO2002067921A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating bipolar disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0303243A2 HUP0303243A2 (hu) | 2004-01-28 |
| HUP0303243A3 true HUP0303243A3 (en) | 2012-07-30 |
Family
ID=26765948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0303243A HUP0303243A3 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing and treating bipolar disorder |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6562867B2 (enExample) |
| EP (1) | EP1408953B1 (enExample) |
| JP (1) | JP4276837B2 (enExample) |
| KR (1) | KR100946944B1 (enExample) |
| CN (1) | CN1250215C (enExample) |
| AT (1) | ATE324108T1 (enExample) |
| BR (1) | BR0207644A (enExample) |
| CA (1) | CA2439475C (enExample) |
| CY (1) | CY1105330T1 (enExample) |
| CZ (1) | CZ20032300A3 (enExample) |
| DE (1) | DE60210976T2 (enExample) |
| DK (1) | DK1408953T3 (enExample) |
| ES (1) | ES2262801T3 (enExample) |
| HU (1) | HUP0303243A3 (enExample) |
| IL (1) | IL157590A0 (enExample) |
| MX (1) | MXPA03007717A (enExample) |
| MY (1) | MY129304A (enExample) |
| NO (1) | NO20033802L (enExample) |
| NZ (1) | NZ527988A (enExample) |
| PL (1) | PL364638A1 (enExample) |
| PT (1) | PT1408953E (enExample) |
| RS (1) | RS50677B (enExample) |
| RU (1) | RU2300372C2 (enExample) |
| TW (1) | TWI250872B (enExample) |
| WO (1) | WO2002067921A1 (enExample) |
| ZA (1) | ZA200307465B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7349301A (en) * | 2000-07-21 | 2002-02-05 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| MXPA03007720A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
| RS51055B (sr) * | 2001-02-27 | 2010-10-31 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja |
| ATE435014T1 (de) | 2001-07-16 | 2009-07-15 | Ortho Mcneil Pharm Inc | Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen |
| RS51269B (sr) * | 2004-09-16 | 2010-12-31 | Janssen Pharmaceutica N.V. | Upotreba 2-fenil-1,2-etandiol-(di)karbamata za tretiranje epileptogeneze |
| KR101335941B1 (ko) | 2005-06-08 | 2013-12-04 | 에스케이바이오팜 주식회사 | 수면-각성 장애의 치료 |
| US20070021501A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods of treating epileptogenesis |
| BRPI0718324A2 (pt) * | 2006-10-30 | 2013-11-26 | Sk Holdings | Métodos para o tratamento de depressão. |
| US20080103199A1 (en) * | 2006-10-31 | 2008-05-01 | Haas Magali | Treatment of pervasive developmental disorders |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| US9566261B2 (en) * | 2013-03-12 | 2017-02-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| EP3556366B1 (en) | 2016-12-14 | 2025-10-22 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder |
| WO2018222954A1 (en) | 2017-06-02 | 2018-12-06 | Jazz Pharmaceuticals International Iii Limited | Methods and compositions for treating excessive sleepiness |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3278380A (en) * | 1962-02-06 | 1966-10-11 | Armour Pharma | Methods of calming employing diphenyl hydroxy carbamate compounds |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| ATE182332T1 (de) * | 1994-06-16 | 1999-08-15 | Pfizer | Pyrazolo und pyrrolopyridine |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 AT AT02724984T patent/ATE324108T1/de active
- 2002-02-21 US US10/081,766 patent/US6562867B2/en not_active Expired - Lifetime
- 2002-02-21 PT PT02724984T patent/PT1408953E/pt unknown
- 2002-02-21 CZ CZ20032300A patent/CZ20032300A3/cs unknown
- 2002-02-21 JP JP2002567288A patent/JP4276837B2/ja not_active Expired - Lifetime
- 2002-02-21 MX MXPA03007717A patent/MXPA03007717A/es active IP Right Grant
- 2002-02-21 EP EP02724984A patent/EP1408953B1/en not_active Expired - Lifetime
- 2002-02-21 PL PL02364638A patent/PL364638A1/xx not_active Application Discontinuation
- 2002-02-21 DE DE60210976T patent/DE60210976T2/de not_active Expired - Lifetime
- 2002-02-21 DK DK02724984T patent/DK1408953T3/da active
- 2002-02-21 BR BR0207644-6A patent/BR0207644A/pt not_active Application Discontinuation
- 2002-02-21 IL IL15759002A patent/IL157590A0/xx not_active IP Right Cessation
- 2002-02-21 WO PCT/US2002/005297 patent/WO2002067921A1/en not_active Ceased
- 2002-02-21 HU HU0303243A patent/HUP0303243A3/hu unknown
- 2002-02-21 CN CNB028089170A patent/CN1250215C/zh not_active Expired - Fee Related
- 2002-02-21 RS YUP-678/03A patent/RS50677B/sr unknown
- 2002-02-21 KR KR1020037011296A patent/KR100946944B1/ko not_active Expired - Lifetime
- 2002-02-21 ES ES02724984T patent/ES2262801T3/es not_active Expired - Lifetime
- 2002-02-21 CA CA2439475A patent/CA2439475C/en not_active Expired - Fee Related
- 2002-02-21 NZ NZ527988A patent/NZ527988A/en unknown
- 2002-02-21 RU RU2003128997/14A patent/RU2300372C2/ru active
- 2002-02-27 TW TW091103500A patent/TWI250872B/zh active
- 2002-02-27 MY MYPI20020691A patent/MY129304A/en unknown
-
2003
- 2003-08-26 NO NO20033802A patent/NO20033802L/no not_active Application Discontinuation
- 2003-09-25 ZA ZA200307465A patent/ZA200307465B/en unknown
-
2006
- 2006-06-21 CY CY20061100844T patent/CY1105330T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0203286D0 (en) | Cyclobenzaprine for treating generalized anziety disorder and compositions thereof | |
| EP1423120A4 (en) | 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF | |
| IL160388A0 (en) | Topical compositions and methods for treating pain | |
| EP1487492A4 (en) | PREVENTION OR TREATMENT OF CANCER USING INTEGRIN ALPHAVBETA3 ANTAGONISTS COMBINED WITH OTHER AGENTS | |
| GB0111872D0 (en) | Therapeutic agents and methods | |
| PL376733A1 (pl) | Środek do zapobiegania lub leczenia neuropatii | |
| GB0109414D0 (en) | Well treatment fluids and methods for the use thereof | |
| IL162447A0 (en) | Methods for slowing senescence and treating and preventing diseases associated with senescence | |
| GB0110288D0 (en) | Composition and treatment method | |
| HUP0303344A3 (en) | Carbamate compounds for use in preventing and treating movement disorders | |
| HUP0303243A3 (en) | Carbamate compounds for use in preventing and treating bipolar disorder | |
| HUP0303264A3 (en) | Carbamate compounds for use in preventing and treating neurodegenerative disorders | |
| HUP0303261A3 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| HUP0400069A3 (en) | Pharmaceutical combinations and their use in preventing and treating the thrombosis | |
| PL368556A1 (en) | Methods for treating or preventing skin disorders using cd2-binding agents | |
| ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
| HUP0303342A3 (en) | Carbamate compounds for use in preventing and treating psychotic disorders | |
| HUP0401913A3 (en) | Medicine for preventing and treating bromhidrosis | |
| HUP0302940A3 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
| SG110107A1 (en) | Compound and use in treatment | |
| GB0119025D0 (en) | Compounds and their therapeutic use | |
| AU2002352925A8 (en) | Method for treating and preventing pancreatitis | |
| TWI318876B (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| PL354111A1 (en) | Combined therapy for treating the both depression and anxiety |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |